Nirmal Lamichhane
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nirmal Lamichhane has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Bhakta Man Shrestha
2 shared publications- Binay Thakur
BP Koirala Memorial Cancer Hospital
2 shared publications Hari Prasad Dhakal
2 shared publicationsPrakash Raj Neupane
2 shared publicationsB K Thakur
Dept. of Surgical Oncology, B.P. Koirala Memorial Cancer Hospital, Bharatpur, Chitwan
1 shared publicationB M Shrestha
Dept. of Surgical Oncology, B.P. Koirala Memorial Cancer Hospital, Bharatpur, Chitwan
1 shared publication
Latest Publications
- Open Access
- 11 October 2019
- Published by Nepal Journals Online (JOL) in Nepalese Journal of Cancer
- Vol. 3 (1) , 1-4
Trans-perineal Prostate Biopsy under Trans-rectal Ultrasound Guidance
Prostate cancer is the most common cancer in males in the western world and is an emerging malignancy in eastern world as well. It is less invasive and easily curable in early stages. It requires efficient and accurate diagnosis strategy to detect it early. To date, the standard diagnosis procedure involves a blind biopsy with a high rate of false negative results. Trans-perineal prostate biopsy is re-emerging after decades of being an underused alternative to trans-rectal biopsy guided by trans-rectal ultrasonography. In order to overcome these limitations, the paper proposes the method and advantages of trans-perineal prostate biopsy.
- 11 October 2019
- Published by Nepal Journals Online (JOL) in Nepalese Journal of Cancer
- Vol. 3 (1) , 1-4
Open AccessTrans-perineal Prostate Biopsy under Trans-rectal Ultrasound Guidance
Prostate cancer is the most common cancer in males in the western world and is an emerging malignancy in eastern world as well. It is less invasive and easily curable in early stages. It requires efficient and accurate diagnosis strategy to detect it early. To date, the standard diagnosis procedure involves a blind biopsy with a high rate of false negative results. Trans-perineal prostate biopsy is re-emerging after decades of being an underused alternative to trans-rectal biopsy guided by trans-rectal ultrasonography. In order to overcome these limitations, the paper proposes the method and advantages of trans-perineal prostate biopsy.
- Open Access
- 31 December 2018
- Published by Nepal Journals Online (JOL) in Journal of Society of Surgeons of Nepal
- Vol. 21 (2) , 32-37
Treatment of advanced rectal cancers: Cylindrical abdominoperineal excision of rectum
Introduction: Treatment for patients with locally advanced low lying rectal cancer differs significantly from patients with rectal cancer restricted to the mesorectum. They require multimodality treatment, including preoperative chemo-radiation and extended surgical resection. Cylindrical abdominoperineal excision of rectum (C-APER) along with possible composite pelvic organ resection is a surgical method to remove an adequate circumferential margin. Method: Patients with the diagnosis of advanced rectal cancers over a period of 9 months are included in this study. Therapeutic approach of C-APER is taken for these patients with focus on multimodality treatment protocols to downstage the tumours and extended resections to enable complete removal of all tumour tissue with clear surgical margins. Consecutive review of cases of advanced rectal cancer to their immediate surgical outcome were done. Results: Five patients with compromised CRM in MRI of rectum, 4 were treated with Neoadjuvant FOLFOX 6 regimen chemotherapy 3 cycles and Short course Radiotherapy. All underwent surgery 6-8 weeks after treatment. The pelvic floor was repaired with biological mesh in 1 and synthetic mesh in 4. The pathological stage of disease remained T3 and above despite neoadjuvant treatment in majority of patients but none of them had positive CRM. The wound complication rates were high in the perineum with serous discharge in almost every patient and one patient needing long term vacuum assisted dressing in the community. Conclusion: The surgery is technically feasible with acceptable morbidity in short term with possible long term outcome of reduced loco-regional failure.
- 31 December 2018
- Published by Nepal Journals Online (JOL) in Journal of Society of Surgeons of Nepal
- Vol. 21 (2) , 32-37
Open AccessTreatment of advanced rectal cancers: Cylindrical abdominoperineal excision of rectum
Introduction: Treatment for patients with locally advanced low lying rectal cancer differs significantly from patients with rectal cancer restricted to the mesorectum. They require multimodality treatment, including preoperative chemo-radiation and extended surgical resection. Cylindrical abdominoperineal excision of rectum (C-APER) along with possible composite pelvic organ resection is a surgical method to remove an adequate circumferential margin. Method: Patients with the diagnosis of advanced rectal cancers over a period of 9 months are included in this study. Therapeutic approach of C-APER is taken for these patients with focus on multimodality treatment protocols to downstage the tumours and extended resections to enable complete removal of all tumour tissue with clear surgical margins. Consecutive review of cases of advanced rectal cancer to their immediate surgical outcome were done. Results: Five patients with compromised CRM in MRI of rectum, 4 were treated with Neoadjuvant FOLFOX 6 regimen chemotherapy 3 cycles and Short course Radiotherapy. All underwent surgery 6-8 weeks after treatment. The pelvic floor was repaired with biological mesh in 1 and synthetic mesh in 4. The pathological stage of disease remained T3 and above despite neoadjuvant treatment in majority of patients but none of them had positive CRM. The wound complication rates were high in the perineum with serous discharge in almost every patient and one patient needing long term vacuum assisted dressing in the community. Conclusion: The surgery is technically feasible with acceptable morbidity in short term with possible long term outcome of reduced loco-regional failure.
- Open Access
- 16 September 2017
- Published by Nepal Journals Online (JOL) in Nepalese Journal of Cancer
- Vol. 1 (1) , 67-70
Melanoma of Urinary Bladder presented as acute urine retention
This report is of a 50-year-old man with a rare urinary bladder melanoma. He presented with hematuria followed by bladder outlet obstruction at the time of presentation. Ultrasonogram of the pelvis revealed a mass in the bladder outlet, suggestive of enlarged prostate. Suprapubic cystostomy was then performed. Subsequent transvesical exploration revealed a dark coloured mass at the outlet of bladder, which on histopathology confirmed to be melanoma. After ruling out other possible primary sites, he underwent radical cysto-urethrectomy with urinary diversion. Disease was confirmed with immunohistochemistry. Patient died after 3 months with bilateral lung metastasis.
- 16 September 2017
- Published by Nepal Journals Online (JOL) in Nepalese Journal of Cancer
- Vol. 1 (1) , 67-70
Open AccessMelanoma of Urinary Bladder presented as acute urine retention
This report is of a 50-year-old man with a rare urinary bladder melanoma. He presented with hematuria followed by bladder outlet obstruction at the time of presentation. Ultrasonogram of the pelvis revealed a mass in the bladder outlet, suggestive of enlarged prostate. Suprapubic cystostomy was then performed. Subsequent transvesical exploration revealed a dark coloured mass at the outlet of bladder, which on histopathology confirmed to be melanoma. After ruling out other possible primary sites, he underwent radical cysto-urethrectomy with urinary diversion. Disease was confirmed with immunohistochemistry. Patient died after 3 months with bilateral lung metastasis.
- Open Access
- 16 September 2017
- Published by Nepal Journals Online (JOL) in Nepalese Journal of Cancer
- Vol. 1 (1) , 58-64
Primary Pancreatic Lymphoma: a rare entity in pancreatic mass
Primary pancreatic lymphoma is an extremely rare tumor of pancreas which clinico-radiologically mimics with pancreatic adenocarcinoma. The disease is diagnosed often after radical resection of pancreas. We report a case of 63 years old Chinese gentle man with diagnosis of Primary pancreatic lymphoma who was diagnose after surgical resection. Primary pancreatic lymphoma should also be considered as differential diagnosis in pancreatic tumors. There can be some radiological clues but accurate diagnosis depends on histopathological examination. Definitive treatment still remains controversial.
- 16 September 2017
- Published by Nepal Journals Online (JOL) in Nepalese Journal of Cancer
- Vol. 1 (1) , 58-64
Open AccessPrimary Pancreatic Lymphoma: a rare entity in pancreatic mass
Primary pancreatic lymphoma is an extremely rare tumor of pancreas which clinico-radiologically mimics with pancreatic adenocarcinoma. The disease is diagnosed often after radical resection of pancreas. We report a case of 63 years old Chinese gentle man with diagnosis of Primary pancreatic lymphoma who was diagnose after surgical resection. Primary pancreatic lymphoma should also be considered as differential diagnosis in pancreatic tumors. There can be some radiological clues but accurate diagnosis depends on histopathological examination. Definitive treatment still remains controversial.
- 1 March 2007
- Vol. 9 (1)
Initial experience in a cancer hospital in Nepal with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer.
To evaluate the performance and feasibility of sentinel lymph node biopsy in early breast cancer patients using patent blue dye. From March 2004, we are consecutively enrolling breast cancer patients with tumor size less than 5 cm with no clinically palpable axillary lymph nodes in this feasibility study. So far, 21 patients underwent sentinel lymph node biopsy using 1.0% patent blue dye injection around the tumor followed by axillary dissection. Sentinel lymph node biopsy was compared with axillary dissection for its ability to accurately reflect the final pathological status of the axillary nodes. Age of patients ranged form 32-67 years old with mean age of 46.72 years. Fifty seven percent of patients were postmenopausal. Patients with T1 lesions were 8 and T2 were 13. The sentinel lymph node/s were successfully identified in 20 out of 21 patients (95.0%). The number of sentinel lymph nodes ranged from 1 to 5 (average 2.0) and non-sentinel nodes ranged from 5-22 (average 12.0). Infiltrating ductal carcinoma was diagnosed in 15 patients, DCIS with early invasion in 4 patients, invasive lobular carcinoma in 1 and medullary carcinoma in 1 patient. Of the 20 patients in whom sentinel lymph nodes were successfully identified, nodes were positive in 35.0% (7/20) of patients. All the positive nodes were detected in group with T2 lesions. SLNs were the only positive nodes in 2 patients. There were no false negative patients, yielding an accuracy of 100.0%. Lymphatic mapping using patent blue dye alone is technically feasible for patients with small (T1 or T2) palpable breast tumors. The sentinel node can be reliably identified in the majority of these patients, and its histology reflects that of the axilla with a high degree of accuracy. This method is very useful in economically backward countries as it involves less expensive material.
- 1 March 2007
- Vol. 9 (1)
Initial experience in a cancer hospital in Nepal with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer.
To evaluate the performance and feasibility of sentinel lymph node biopsy in early breast cancer patients using patent blue dye. From March 2004, we are consecutively enrolling breast cancer patients with tumor size less than 5 cm with no clinically palpable axillary lymph nodes in this feasibility study. So far, 21 patients underwent sentinel lymph node biopsy using 1.0% patent blue dye injection around the tumor followed by axillary dissection. Sentinel lymph node biopsy was compared with axillary dissection for its ability to accurately reflect the final pathological status of the axillary nodes. Age of patients ranged form 32-67 years old with mean age of 46.72 years. Fifty seven percent of patients were postmenopausal. Patients with T1 lesions were 8 and T2 were 13. The sentinel lymph node/s were successfully identified in 20 out of 21 patients (95.0%). The number of sentinel lymph nodes ranged from 1 to 5 (average 2.0) and non-sentinel nodes ranged from 5-22 (average 12.0). Infiltrating ductal carcinoma was diagnosed in 15 patients, DCIS with early invasion in 4 patients, invasive lobular carcinoma in 1 and medullary carcinoma in 1 patient. Of the 20 patients in whom sentinel lymph nodes were successfully identified, nodes were positive in 35.0% (7/20) of patients. All the positive nodes were detected in group with T2 lesions. SLNs were the only positive nodes in 2 patients. There were no false negative patients, yielding an accuracy of 100.0%. Lymphatic mapping using patent blue dye alone is technically feasible for patients with small (T1 or T2) palpable breast tumors. The sentinel node can be reliably identified in the majority of these patients, and its histology reflects that of the axilla with a high degree of accuracy. This method is very useful in economically backward countries as it involves less expensive material.
- 1 December 2006
- Vol. 8 (4)
Ganglioneuroma of pelvis--an unique presentation in a young man.
Ganglioneuromas presented as a pelvic tumor around the pelvic organs is a rare entity. A case with unusual presentation is reported. Young man of 18 years old presented with a complaint of lower abdominal mass increasing in size for last 3 years. It was treated with partial resection for debulking purpose after the conformation during surgery with frozen section. Debulking surgery with preservation of organ functions is feasible in these slow growing tumors for better quality of life.
- 1 December 2006
- Vol. 8 (4)
Ganglioneuroma of pelvis--an unique presentation in a young man.
Ganglioneuromas presented as a pelvic tumor around the pelvic organs is a rare entity. A case with unusual presentation is reported. Young man of 18 years old presented with a complaint of lower abdominal mass increasing in size for last 3 years. It was treated with partial resection for debulking purpose after the conformation during surgery with frozen section. Debulking surgery with preservation of organ functions is feasible in these slow growing tumors for better quality of life.
- 1 June 2005
- Vol. 7 (1)
Retrospective study of chest wall tumors at a cancer hospital in Nepal.
Primary and metastatic tumors of both soft tissues and bony skeleton, and primary tumors of adjacent organs invading the chest wall constitute chest wall tumors. A retrospective review of all the patients with chest wall tumors was done at BP Koirala Memorial Cancer Hospital (BPKMCH). Primary tumors of breast were excluded. Surgical treatment consisted of wide local excision (WLE). Chest wall reconstruction, if needed, was achieved by a muscular flap +/- prolene mesh +/- omental transposition. Thirty one patients were treated in the period from October 1999 to October 2003. Age of the patients varied from 3 years to 72 years (mean age--38 years). Presenting complaint was mass in 96.8% and pain in 48.4% cases. The mass was 5 cm or less in 34.4%, from 5 to 10 cm in 32.3%, and more than 10 cm in 32.3% cases. The lesions were located in sternal region, anterior, lateral, posterior, and vertebral chest wall in 6.5%, 32.3%, 41.9%, 16.1% and 3.2% respectively. WLE was done in 29 cases. Chest wall reconstruction using both muscular flaps and prolene mesh (15x15 cm) was done in 8 cases. In three of them, where concomitant wedge resection of the lung was done, omental transposition was added. In rest of the cases, primary closure, muscular/myocutaneous flap or skin grafting was done. Minor complications were observed in 31.0% cases, which were managed conservatively. Two patients received adjuvant radiotherapy and four patients--adjuvant chemotherapy. There were no postoperative deaths. The rate of malignancy was 48.4%.
- 1 June 2005
- Vol. 7 (1)
Retrospective study of chest wall tumors at a cancer hospital in Nepal.
Primary and metastatic tumors of both soft tissues and bony skeleton, and primary tumors of adjacent organs invading the chest wall constitute chest wall tumors. A retrospective review of all the patients with chest wall tumors was done at BP Koirala Memorial Cancer Hospital (BPKMCH). Primary tumors of breast were excluded. Surgical treatment consisted of wide local excision (WLE). Chest wall reconstruction, if needed, was achieved by a muscular flap +/- prolene mesh +/- omental transposition. Thirty one patients were treated in the period from October 1999 to October 2003. Age of the patients varied from 3 years to 72 years (mean age--38 years). Presenting complaint was mass in 96.8% and pain in 48.4% cases. The mass was 5 cm or less in 34.4%, from 5 to 10 cm in 32.3%, and more than 10 cm in 32.3% cases. The lesions were located in sternal region, anterior, lateral, posterior, and vertebral chest wall in 6.5%, 32.3%, 41.9%, 16.1% and 3.2% respectively. WLE was done in 29 cases. Chest wall reconstruction using both muscular flaps and prolene mesh (15x15 cm) was done in 8 cases. In three of them, where concomitant wedge resection of the lung was done, omental transposition was added. In rest of the cases, primary closure, muscular/myocutaneous flap or skin grafting was done. Minor complications were observed in 31.0% cases, which were managed conservatively. Two patients received adjuvant radiotherapy and four patients--adjuvant chemotherapy. There were no postoperative deaths. The rate of malignancy was 48.4%.
- Open Access
- 8 September 2004
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 80 (947) , 546-550
Sentinel lymph node biopsy in breast cancer patients after overnight migration of radiolabelled sulphur colloid
Objective: To evaluate the performance and feasibility of sentinel lymph node biopsy in breast cancer patients using technetium-99m (99mTc) sulphur colloid and gamma probe. Methods: From May 2000 to March 2001, 70 patients with a tumour less than 5 cm with clinically negative axillary lymph nodes underwent sentinel node biopsy followed by standard axillary dissection. 99mTc sulphur colloid was injected around the primary tumour the day before surgery and a gamma probe was used to detect the sentinel lymph node during the surgical procedure. Sentinel lymph node biopsy was compared with standard axillary dissection for its ability to accurately reflect the final pathological status of the axillary nodes. Results: The sentinel lymph node was successfully identified in 67 of 70 patients (95.71%). The number of sentinel lymph nodes ranged from 1–5 (mean 1.5) and non-sentinel nodes ranged from 5–22 (mean 13.3). Of the 67 patients with successfully identified sentinel lymph nodes, 43.28% (29/67) were histologically positive. Sensitivity of the sentinel lymph node to predict axilla was 82.75%; specificity was 100%. Positive and negative predictive values were 100% and 88.3% respectively. The sentinel lymph node was falsely negative in five patients, yielding an accuracy of 92.53%. Sentinel lymph node biopsy was more accurate for T1 tumours than for T2 tumours. Conclusions: The gamma probe guided method after overnight migration of 99mTc sulphur colloid is technically feasible for detecting sentinel lymph nodes in most breast cancer patients, accurately predicting the axillary lymph node status, and appears more accurate for T1 lesions than for larger lesions. This minimally invasive axillary staging procedure represents a major advance in the surgical treatment of breast cancer.
- 8 September 2004
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 80 (947) , 546-550
Open AccessSentinel lymph node biopsy in breast cancer patients after overnight migration of radiolabelled sulphur colloid
Objective: To evaluate the performance and feasibility of sentinel lymph node biopsy in breast cancer patients using technetium-99m (99mTc) sulphur colloid and gamma probe. Methods: From May 2000 to March 2001, 70 patients with a tumour less than 5 cm with clinically negative axillary lymph nodes underwent sentinel node biopsy followed by standard axillary dissection. 99mTc sulphur colloid was injected around the primary tumour the day before surgery and a gamma probe was used to detect the sentinel lymph node during the surgical procedure. Sentinel lymph node biopsy was compared with standard axillary dissection for its ability to accurately reflect the final pathological status of the axillary nodes. Results: The sentinel lymph node was successfully identified in 67 of 70 patients (95.71%). The number of sentinel lymph nodes ranged from 1–5 (mean 1.5) and non-sentinel nodes ranged from 5–22 (mean 13.3). Of the 67 patients with successfully identified sentinel lymph nodes, 43.28% (29/67) were histologically positive. Sensitivity of the sentinel lymph node to predict axilla was 82.75%; specificity was 100%. Positive and negative predictive values were 100% and 88.3% respectively. The sentinel lymph node was falsely negative in five patients, yielding an accuracy of 92.53%. Sentinel lymph node biopsy was more accurate for T1 tumours than for T2 tumours. Conclusions: The gamma probe guided method after overnight migration of 99mTc sulphur colloid is technically feasible for detecting sentinel lymph nodes in most breast cancer patients, accurately predicting the axillary lymph node status, and appears more accurate for T1 lesions than for larger lesions. This minimally invasive axillary staging procedure represents a major advance in the surgical treatment of breast cancer.
- Open Access
- 1 September 2003
- Published by Journal of Nepal Medical Association (JNMA) in Journal of Nepal Medical Association
- Vol. 42 (149) , 290-3
SURGICAL TREATMENT OF CARCINOMA OESOPHAGUS AT B P KOIRALA MEMORIAL CANCER HOSPITAL, BHARATPUR
To review resectability, lymph node status and post-operative complications in cases of carcinoma ofoesophagus treated surgically at B P Koirala memorial cancer hospital (BPKMCH), we reviewed the medicalrecords of 16 surgically treated cases of carcinoma oesophagus from January 2001 to March 2002. Therewere 5 patients in stage IIa and 9 patients in stage III. Tumor was resectable in 14 out of 16 patients (87.5%).There was no perioperative mortality. Anastomotic leak was seen in one case. Out of 14 resected specimens,7 (50%) of them had lymph node metastasis. Oesophagectomy is a safe procedure if done in a well-selected group of patients. Resectability is considerably high with minimal perioperative complications.Key Words: Carcinoma oesophagus, surgical therapy, lymphnode metastasis.
- 1 September 2003
- Published by Journal of Nepal Medical Association (JNMA) in Journal of Nepal Medical Association
- Vol. 42 (149) , 290-3
Open AccessSURGICAL TREATMENT OF CARCINOMA OESOPHAGUS AT B P KOIRALA MEMORIAL CANCER HOSPITAL, BHARATPUR
To review resectability, lymph node status and post-operative complications in cases of carcinoma ofoesophagus treated surgically at B P Koirala memorial cancer hospital (BPKMCH), we reviewed the medicalrecords of 16 surgically treated cases of carcinoma oesophagus from January 2001 to March 2002. Therewere 5 patients in stage IIa and 9 patients in stage III. Tumor was resectable in 14 out of 16 patients (87.5%).There was no perioperative mortality. Anastomotic leak was seen in one case. Out of 14 resected specimens,7 (50%) of them had lymph node metastasis. Oesophagectomy is a safe procedure if done in a well-selected group of patients. Resectability is considerably high with minimal perioperative complications.Key Words: Carcinoma oesophagus, surgical therapy, lymphnode metastasis.